Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2004 1
2005 1
2011 1
2014 1
2015 2
2016 1
2017 2
2018 1
2021 3
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
Ebola virus antibody decay-stimulation in a high proportion of survivors.
Adaken C, Scott JT, Sharma R, Gopal R, Dicks S, Niazi S, Ijaz S, Edwards T, Smith CC, Cole CP, Kamara P, Kargbo O, Doughty HA, van Griensven J, Horby PW, Gevao SM, Sahr F; Ebola-CP Consortium; Dimelow RJ, Tedder RS, Semple MG, Paxton WA, Pollakis G. Adaken C, et al. Among authors: kamara p. Nature. 2021 Feb;590(7846):468-472. doi: 10.1038/s41586-020-03146-y. Epub 2021 Jan 27. Nature. 2021. PMID: 33505020 Free PMC article.
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS, Warsame M, Vonhm B, Jeuronlon MK, Menard D, Ma L, Taweh F, Tehmeh L, Nyansaiye P, Pratt OJ, Parwon S, Kamara P, Asinya M, Kollie A, Ringwald P. Koko VS, et al. Among authors: kamara p. Malar J. 2022 Apr 27;21(1):134. doi: 10.1186/s12936-022-04140-7. Malar J. 2022. PMID: 35477399 Free PMC article.
Innovations to reduce maternal mortality and improve health and wellbeing of adolescent girls and their babies in Sierra Leone.
Turienzo CF, November L, Kamara M, Kamara P, Goodhart V, Ridout A, Sam B, Thomas S, Williams PT, Sandall J, Shennan AH; CRIBS Collaborative Group. Turienzo CF, et al. Among authors: kamara p. Lancet Child Adolesc Health. 2023 Mar;7(3):151-153. doi: 10.1016/S2352-4642(22)00322-4. Epub 2022 Nov 25. Lancet Child Adolesc Health. 2023. PMID: 36442481 No abstract available.
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.
Tedder RS, Samuel D, Dicks S, Scott JT, Ijaz S, Smith CC, Adaken C, Cole C, Baker S, Edwards T, Kamara P, Kargbo O, Niazi S, Nwakanma D, d'Alessandro U, Burch G, Doughty H, Brown CS, Andrews N, Glynn JR, van Griensven J; Ebola_CP Consortium Investigators; Pollakis G, Paxton WA, Semple MG. Tedder RS, et al. Among authors: kamara p. Transfusion. 2018 May;58(5):1289-1298. doi: 10.1111/trf.14580. Epub 2018 Mar 23. Transfusion. 2018. PMID: 29572862 Free PMC article.
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team. Yin DE, et al. Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527. Pediatrics. 2014. PMID: 25266426 Free PMC article. Clinical Trial.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Afolabi MO, Ishola D, Manno D, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Greenwood B, Leyssen M, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group. Afolabi MO, et al. Lancet Infect Dis. 2022 Jan;22(1):110-122. doi: 10.1016/S1473-3099(21)00128-6. Epub 2021 Sep 13. Lancet Infect Dis. 2022. PMID: 34529962 Free PMC article. Clinical Trial.
20 results